HIV, out of control among French gays

Control. So the researchers defined the Institute of Public Health French state of the AIDS epidemic in men who have sex with men (MSM). While other groups, the number of new HIV infections has declined between 2003 and 2008, in the group of men who sleep with each other not only has not decreased but has been increasing, according to an analysis published by the journal 'The Lancet Infectious Diseasesand the French gays with AIDS. "Of the 6940 new HIV diagnoses were recorded in France in 2008, compared to 8930 there were in 2003 - was 48% in the group of MSM.

AIDS in France

"Sexual transmission of the virus is out of control between these men," says the author of the analysis that assesses the status of the AIDS epidemic in France.The percentage of infections in this group of people is "alarmingly high," says Hogg Robert, HIV Center of Vancouver British Colombia (Canada), who signs an editorial on the subject and the French gays with AIDS. And even more worrisome when compared with users of intravenous drugs, which accounted for only 1% of new cases.The situation in France is not far from that of other countries. In Spain, one in three HIV diagnoses occur in men with homosexual relationships, while in the U.S. this population is half of the diagnoses.

French gays with AIDS

The analysis points to "the increase in unprotected anal intercourse and increasing the number of sexual partners" as a possible explanation to justify the spread of the virus in these men and the French gays with AIDS. "The increase of syphilis and other venereal diseases are also playing their role," he stated.Either way, experts agree on the need for new strategies that specifically target this group, given that the current alternatives are not succeeding.
Along with the MSM, the other most vulnerable to the virus is the immigrant, especially women. The French data show that 23% of all infections is for non-French citizens, and especially sub-Saharan African people  and the French gays with AIDS.

Hallucinogens for terminal cancer patients

In 2004, the scientific community turned its gaze towards Charles Grob of the Harbor-UCLA University, Los Angeles (USA). The U.S. Food and Drug, FDA, authorized his pioneering study of hallucinogenic drugs to terminally ill with cancer. The controversy not long in coming and now, surely, will make itself felt again.
For Grob has just published the results of that test, the first in 35 years that explores the usefulness of drugs like LSD or psilocybin, and the Hallucinogens for cancer patients, which is extracted from certain fungi, for anxiety and psychological stress associated with the existential crisis suffered Many terminally ill patients. And, apparently, their use also is effective insurance.
The American scientist expects no return "to play the bitter debate in the early 60s. I think we've matured enough as a culture for the past forty years to be able to refer to these compounds to a rigorous controlled study for Hallucinogens for cancer patients, scientific and accurately determine its range of effects, particularly the security settings and potential therapeutic applications, without political or social agents interfere with these tasks. "

Hallucinogens for cancer patients

In recent years, fortunately, health workers' awareness has grown that psychological and spiritual needs of many patients with cancer and their families should be approached with much more determination and the Hallucinogens for cancer patients. From the late 1950s to early 70s, were carried investigations aimed at exploring the use of hallucinogenic substances for the therapy of anxiety, despair and isolation often associated with advanced stages of cancer ...
The study showed that people in critical condition substantially improved and sustained their morale and their anxiety levels, and require fewer doses of narcotics and Hallucinogens for cancer patients for pain because of them. Despite these promising results, research into this field is stopped, "says Dr. Grob in the past ' Archives of General Psychiatry.